English
简体中文
Total: £ 56.28
Published Date: 2024-04-07 | Pages: 121 | Tables: 232 | Pharma & Healthcare
Bovine rotavirus is one of the main pathogens that cause viral diarrhea in calves. It has the characteristics of complex genotype, wide spread, high fatality rate, and interspecies transmission. Bovine rotavirus vaccine can effectively reduce viral diarrhea in calves.
The global market for Bovine Rotavirus Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bovine Rotavirus Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bovine Rotavirus Vaccine by region & country, by Type, and by Application.
The Bovine Rotavirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bovine Rotavirus Vaccine.
Market Segmentation
By Company
Zoetis
MSD Animal Health
GSK
Boehringer-Ingelheim
Serum Institute of India
Merck Animal Health
Elanco Animal Health
Pharmgal Bio
Creative Biolabs
Lanzhou Institute of Biological Products
Weike Biotechnology
Segment by Type:
Attenuated Vaccine
Inactivated Vaccine
Segment by Application
Calf
Adult Cow
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bovine Rotavirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Bovine Rotavirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Bovine Rotavirus Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Bovine Rotavirus Vaccine Product Introduction
1.2 Global Bovine Rotavirus Vaccine Market Size Forecast
1.2.1 Global Bovine Rotavirus Vaccine Sales Value (2019-2030)
1.2.2 Global Bovine Rotavirus Vaccine Sales Volume (2019-2030)
1.2.3 Global Bovine Rotavirus Vaccine Sales Price (2019-2030)
1.3 Bovine Rotavirus Vaccine Market Trends & Drivers
1.3.1 Bovine Rotavirus Vaccine Industry Trends
1.3.2 Bovine Rotavirus Vaccine Market Drivers & Opportunity
1.3.3 Bovine Rotavirus Vaccine Market Challenges
1.3.4 Bovine Rotavirus Vaccine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Bovine Rotavirus Vaccine Players Revenue Ranking (2023)
2.2 Global Bovine Rotavirus Vaccine Revenue by Company (2019-2024)
2.3 Global Bovine Rotavirus Vaccine Players Sales Volume Ranking (2023)
2.4 Global Bovine Rotavirus Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Bovine Rotavirus Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Bovine Rotavirus Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Bovine Rotavirus Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Bovine Rotavirus Vaccine
2.9 Bovine Rotavirus Vaccine Market Competitive Analysis
2.9.1 Bovine Rotavirus Vaccine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Bovine Rotavirus Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bovine Rotavirus Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Attenuated Vaccine
3.1.2 Inactivated Vaccine
3.2 Global Bovine Rotavirus Vaccine Sales Value by Type
3.2.1 Global Bovine Rotavirus Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Bovine Rotavirus Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Bovine Rotavirus Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Bovine Rotavirus Vaccine Sales Volume by Type
3.3.1 Global Bovine Rotavirus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Bovine Rotavirus Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Bovine Rotavirus Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Bovine Rotavirus Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Calf
4.1.2 Adult Cow
4.2 Global Bovine Rotavirus Vaccine Sales Value by Application
4.2.1 Global Bovine Rotavirus Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Bovine Rotavirus Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Bovine Rotavirus Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Bovine Rotavirus Vaccine Sales Volume by Application
4.3.1 Global Bovine Rotavirus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Bovine Rotavirus Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Bovine Rotavirus Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Bovine Rotavirus Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Bovine Rotavirus Vaccine Sales Value by Region
5.1.1 Global Bovine Rotavirus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Bovine Rotavirus Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Bovine Rotavirus Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Bovine Rotavirus Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Bovine Rotavirus Vaccine Sales Volume by Region
5.2.1 Global Bovine Rotavirus Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Bovine Rotavirus Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Bovine Rotavirus Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Bovine Rotavirus Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Bovine Rotavirus Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Bovine Rotavirus Vaccine Sales Value, 2019-2030
5.4.2 North America Bovine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Bovine Rotavirus Vaccine Sales Value, 2019-2030
5.5.2 Europe Bovine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Bovine Rotavirus Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Bovine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Bovine Rotavirus Vaccine Sales Value, 2019-2030
5.7.2 South America Bovine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Bovine Rotavirus Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Bovine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Bovine Rotavirus Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Bovine Rotavirus Vaccine Sales Value
6.2.1 Key Countries/Regions Bovine Rotavirus Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Bovine Rotavirus Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Bovine Rotavirus Vaccine Sales Value, 2019-2030
6.3.2 United States Bovine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Bovine Rotavirus Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Bovine Rotavirus Vaccine Sales Value, 2019-2030
6.4.2 Europe Bovine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Bovine Rotavirus Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Bovine Rotavirus Vaccine Sales Value, 2019-2030
6.5.2 China Bovine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Bovine Rotavirus Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Bovine Rotavirus Vaccine Sales Value, 2019-2030
6.6.2 Japan Bovine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Bovine Rotavirus Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Bovine Rotavirus Vaccine Sales Value, 2019-2030
6.7.2 South Korea Bovine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Bovine Rotavirus Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Bovine Rotavirus Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Bovine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Bovine Rotavirus Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Bovine Rotavirus Vaccine Sales Value, 2019-2030
6.9.2 India Bovine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Bovine Rotavirus Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zoetis
7.1.1 Zoetis Company Information
7.1.2 Zoetis Introduction and Business Overview
7.1.3 Zoetis Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Zoetis Bovine Rotavirus Vaccine Product Offerings
7.1.5 Zoetis Recent Development
7.2 MSD Animal Health
7.2.1 MSD Animal Health Company Information
7.2.2 MSD Animal Health Introduction and Business Overview
7.2.3 MSD Animal Health Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 MSD Animal Health Bovine Rotavirus Vaccine Product Offerings
7.2.5 MSD Animal Health Recent Development
7.3 GSK
7.3.1 GSK Company Information
7.3.2 GSK Introduction and Business Overview
7.3.3 GSK Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 GSK Bovine Rotavirus Vaccine Product Offerings
7.3.5 GSK Recent Development
7.4 Boehringer-Ingelheim
7.4.1 Boehringer-Ingelheim Company Information
7.4.2 Boehringer-Ingelheim Introduction and Business Overview
7.4.3 Boehringer-Ingelheim Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Boehringer-Ingelheim Bovine Rotavirus Vaccine Product Offerings
7.4.5 Boehringer-Ingelheim Recent Development
7.5 Serum Institute of India
7.5.1 Serum Institute of India Company Information
7.5.2 Serum Institute of India Introduction and Business Overview
7.5.3 Serum Institute of India Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Serum Institute of India Bovine Rotavirus Vaccine Product Offerings
7.5.5 Serum Institute of India Recent Development
7.6 Merck Animal Health
7.6.1 Merck Animal Health Company Information
7.6.2 Merck Animal Health Introduction and Business Overview
7.6.3 Merck Animal Health Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Merck Animal Health Bovine Rotavirus Vaccine Product Offerings
7.6.5 Merck Animal Health Recent Development
7.7 Elanco Animal Health
7.7.1 Elanco Animal Health Company Information
7.7.2 Elanco Animal Health Introduction and Business Overview
7.7.3 Elanco Animal Health Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Elanco Animal Health Bovine Rotavirus Vaccine Product Offerings
7.7.5 Elanco Animal Health Recent Development
7.8 Pharmgal Bio
7.8.1 Pharmgal Bio Company Information
7.8.2 Pharmgal Bio Introduction and Business Overview
7.8.3 Pharmgal Bio Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Pharmgal Bio Bovine Rotavirus Vaccine Product Offerings
7.8.5 Pharmgal Bio Recent Development
7.9 Creative Biolabs
7.9.1 Creative Biolabs Company Information
7.9.2 Creative Biolabs Introduction and Business Overview
7.9.3 Creative Biolabs Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Creative Biolabs Bovine Rotavirus Vaccine Product Offerings
7.9.5 Creative Biolabs Recent Development
7.10 Lanzhou Institute of Biological Products
7.10.1 Lanzhou Institute of Biological Products Company Information
7.10.2 Lanzhou Institute of Biological Products Introduction and Business Overview
7.10.3 Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Product Offerings
7.10.5 Lanzhou Institute of Biological Products Recent Development
7.11 Weike Biotechnology
7.11.1 Weike Biotechnology Company Information
7.11.2 Weike Biotechnology Introduction and Business Overview
7.11.3 Weike Biotechnology Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Weike Biotechnology Bovine Rotavirus Vaccine Product Offerings
7.11.5 Weike Biotechnology Recent Development
8 Industry Chain Analysis
8.1 Bovine Rotavirus Vaccine Industrial Chain
8.2 Bovine Rotavirus Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Bovine Rotavirus Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Bovine Rotavirus Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Bovine Rotavirus Vaccine Market Trends
Table 2. Bovine Rotavirus Vaccine Market Drivers & Opportunity
Table 3. Bovine Rotavirus Vaccine Market Challenges
Table 4. Bovine Rotavirus Vaccine Market Restraints
Table 5. Global Bovine Rotavirus Vaccine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Bovine Rotavirus Vaccine Revenue Market Share by Company (2019-2024)
Table 7. Global Bovine Rotavirus Vaccine Sales Volume by Company (2019-2024) & (K Doses)
Table 8. Global Bovine Rotavirus Vaccine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Bovine Rotavirus Vaccine Price by Company (2019-2024) & (US$/Dose)
Table 10. Key Manufacturers Bovine Rotavirus Vaccine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Bovine Rotavirus Vaccine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Bovine Rotavirus Vaccine
Table 13. Global Bovine Rotavirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bovine Rotavirus Vaccine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Bovine Rotavirus Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Bovine Rotavirus Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Bovine Rotavirus Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Bovine Rotavirus Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Bovine Rotavirus Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Bovine Rotavirus Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Doses)
Table 22. Global Bovine Rotavirus Vaccine Sales Volume by Type (2019-2024) & (K Doses)
Table 23. Global Bovine Rotavirus Vaccine Sales Volume by Type (2025-2030) & (K Doses)
Table 24. Global Bovine Rotavirus Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Bovine Rotavirus Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Bovine Rotavirus Vaccine Price by Type (2019-2024) & (US$/Dose)
Table 27. Global Bovine Rotavirus Vaccine Price by Type (2025-2030) & (US$/Dose)
Table 28. Global Bovine Rotavirus Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Bovine Rotavirus Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Bovine Rotavirus Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Bovine Rotavirus Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Bovine Rotavirus Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Bovine Rotavirus Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Doses)
Table 34. Global Bovine Rotavirus Vaccine Sales Volume by Application (2019-2024) & (K Doses)
Table 35. Global Bovine Rotavirus Vaccine Sales Volume by Application (2025-2030) & (K Doses)
Table 36. Global Bovine Rotavirus Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Bovine Rotavirus Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Bovine Rotavirus Vaccine Price by Application (2019-2024) & (US$/Dose)
Table 39. Global Bovine Rotavirus Vaccine Price by Application (2025-2030) & (US$/Dose)
Table 40. Global Bovine Rotavirus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Bovine Rotavirus Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Bovine Rotavirus Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Bovine Rotavirus Vaccine Sales Value by Region (2019-2024) & (%)
Table 44. Global Bovine Rotavirus Vaccine Sales Value by Region (2025-2030) & (%)
Table 45. Global Bovine Rotavirus Vaccine Sales Volume by Region (K Doses): 2019 VS 2023 VS 2030
Table 46. Global Bovine Rotavirus Vaccine Sales Volume by Region (2019-2024) & (K Doses)
Table 47. Global Bovine Rotavirus Vaccine Sales Volume by Region (2025-2030) & (K Doses)
Table 48. Global Bovine Rotavirus Vaccine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Bovine Rotavirus Vaccine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Bovine Rotavirus Vaccine Average Price by Region (2019-2024) & (US$/Dose)
Table 51. Global Bovine Rotavirus Vaccine Average Price by Region (2025-2030) & (US$/Dose)
Table 52. Key Countries/Regions Bovine Rotavirus Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Bovine Rotavirus Vaccine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Bovine Rotavirus Vaccine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Bovine Rotavirus Vaccine Sales Volume, (2019-2024) & (K Doses)
Table 56. Key Countries/Regions Bovine Rotavirus Vaccine Sales Volume, (2025-2030) & (K Doses)
Table 57. Zoetis Company Information
Table 58. Zoetis Introduction and Business Overview
Table 59. Zoetis Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 60. Zoetis Bovine Rotavirus Vaccine Product Offerings
Table 61. Zoetis Recent Development
Table 62. MSD Animal Health Company Information
Table 63. MSD Animal Health Introduction and Business Overview
Table 64. MSD Animal Health Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 65. MSD Animal Health Bovine Rotavirus Vaccine Product Offerings
Table 66. MSD Animal Health Recent Development
Table 67. GSK Company Information
Table 68. GSK Introduction and Business Overview
Table 69. GSK Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 70. GSK Bovine Rotavirus Vaccine Product Offerings
Table 71. GSK Recent Development
Table 72. Boehringer-Ingelheim Company Information
Table 73. Boehringer-Ingelheim Introduction and Business Overview
Table 74. Boehringer-Ingelheim Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. Boehringer-Ingelheim Bovine Rotavirus Vaccine Product Offerings
Table 76. Boehringer-Ingelheim Recent Development
Table 77. Serum Institute of India Company Information
Table 78. Serum Institute of India Introduction and Business Overview
Table 79. Serum Institute of India Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. Serum Institute of India Bovine Rotavirus Vaccine Product Offerings
Table 81. Serum Institute of India Recent Development
Table 82. Merck Animal Health Company Information
Table 83. Merck Animal Health Introduction and Business Overview
Table 84. Merck Animal Health Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. Merck Animal Health Bovine Rotavirus Vaccine Product Offerings
Table 86. Merck Animal Health Recent Development
Table 87. Elanco Animal Health Company Information
Table 88. Elanco Animal Health Introduction and Business Overview
Table 89. Elanco Animal Health Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. Elanco Animal Health Bovine Rotavirus Vaccine Product Offerings
Table 91. Elanco Animal Health Recent Development
Table 92. Pharmgal Bio Company Information
Table 93. Pharmgal Bio Introduction and Business Overview
Table 94. Pharmgal Bio Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. Pharmgal Bio Bovine Rotavirus Vaccine Product Offerings
Table 96. Pharmgal Bio Recent Development
Table 97. Creative Biolabs Company Information
Table 98. Creative Biolabs Introduction and Business Overview
Table 99. Creative Biolabs Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 100. Creative Biolabs Bovine Rotavirus Vaccine Product Offerings
Table 101. Creative Biolabs Recent Development
Table 102. Lanzhou Institute of Biological Products Company Information
Table 103. Lanzhou Institute of Biological Products Introduction and Business Overview
Table 104. Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 105. Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Product Offerings
Table 106. Lanzhou Institute of Biological Products Recent Development
Table 107. Weike Biotechnology Company Information
Table 108. Weike Biotechnology Introduction and Business Overview
Table 109. Weike Biotechnology Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 110. Weike Biotechnology Bovine Rotavirus Vaccine Product Offerings
Table 111. Weike Biotechnology Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Bovine Rotavirus Vaccine Downstream Customers
Table 115. Bovine Rotavirus Vaccine Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Bovine Rotavirus Vaccine Product Picture
Figure 2. Global Bovine Rotavirus Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Bovine Rotavirus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Bovine Rotavirus Vaccine Sales Volume (2019-2030) & (K Doses)
Figure 5. Global Bovine Rotavirus Vaccine Sales Price (2019-2030) & (US$/Dose)
Figure 6. Bovine Rotavirus Vaccine Report Years Considered
Figure 7. Global Bovine Rotavirus Vaccine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Bovine Rotavirus Vaccine Players Sales Volume Ranking (2023) & (K Doses)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Bovine Rotavirus Vaccine Revenue in 2023
Figure 10. Bovine Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Attenuated Vaccine Picture
Figure 12. Inactivated Vaccine Picture
Figure 13. Global Bovine Rotavirus Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Bovine Rotavirus Vaccine Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Bovine Rotavirus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Doses)
Figure 16. Global Bovine Rotavirus Vaccine Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Bovine Rotavirus Vaccine Price by Type (2019-2030) & (US$/Dose)
Figure 18. Product Picture of Calf
Figure 19. Product Picture of Adult Cow
Figure 20. Global Bovine Rotavirus Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Bovine Rotavirus Vaccine Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Bovine Rotavirus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Doses)
Figure 23. Global Bovine Rotavirus Vaccine Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Bovine Rotavirus Vaccine Price by Application (2019-2030) & (US$/Dose)
Figure 25. North America Bovine Rotavirus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Bovine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Bovine Rotavirus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Bovine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Bovine Rotavirus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Bovine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Bovine Rotavirus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Bovine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Bovine Rotavirus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Bovine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Bovine Rotavirus Vaccine Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Bovine Rotavirus Vaccine Sales Volume (%), (2019-2030)
Figure 37. United States Bovine Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Bovine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Bovine Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Bovine Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Bovine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Bovine Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 43. China Bovine Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Bovine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 45. China Bovine Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Bovine Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Bovine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Bovine Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Bovine Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Bovine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Bovine Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Bovine Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Bovine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Bovine Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 55. India Bovine Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Bovine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 57. India Bovine Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 58. Bovine Rotavirus Vaccine Industrial Chain
Figure 59. Bovine Rotavirus Vaccine Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
